Toxin-Antitoxin systems: Their role in persistence, biofilm formation, and pathogenicity

Pathogens and Disease

Volumn 70, Issue 3, 2014, Pages 240-249

  Wen, Yurong ^a   Behiels, Ester ^a   Devreese, Bart ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Antibiotic resistance; Biofilm; Cell death; Microbiology

Indexed keywords

ANTIINFECTIVE AGENT; ANTITOXIN; TOXIN;

BACTERIAL VIRULENCE; BIOFILM; CELL DIVISION; CELL WALL; DRUG SYNTHESIS; ENVIRONMENTAL FACTOR; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; NONHUMAN; PATHOGENICITY; PLASMID; PRIORITY JOURNAL; SHORT SURVEY; CLASSIFICATION; DRUG DEVELOPMENT; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; PHYSIOLOGY; VIRULENCE;

ANTI-INFECTIVE AGENTS; ANTITOXINS; BIOFILMS; DRUG DISCOVERY; HUMANS; TOXINS, BIOLOGICAL; VIRULENCE;

EID: 84921281896     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12145     Document Type: Short Survey

References (106)

1. Aakre CD, Phung TN, Huang D., Laub MT (2013) A bacterial toxin inhibits DNA replication elongation through a direct interaction with the b sliding clamp. Mol Cell 52: 617-628.
2. Aizenman E, Engelberg-Kulka H., Glaser G (1996) An Escherichia coli chromosomal "addiction module" regulated by 30,50-bispyrophosphate: a model for programmed bacterial cell death. P Natl Acad Sci USA 93: 6059-6063.
3. Amato SM, Orman MA., Brynildsen MP (2013) Metabolic control of persister formation in Escherichia coli. Mol Cell 50: 475-487.
4. Audoly G, Vincentelli R, Edouard S, Georgiades K, Mediannikov O, Gimenez G, Socolovschi C, Mége JL, Cambillau C., Raoult D (2011) Effect of rickettsial toxin VapC on its eukaryotic host. PLoS One 6: e26528.
5. Balaban NQ, Merrin J, Chait R, Kowalik L., Leibler S (2004) Bacterial persistence as a phenotypic switch. Science 305: 1622-1625.
6. Barrios AFG, Zuo R, Yang L, Bentley WE, Thomas K, Gonza F, Hashimoto Y., Wood TK (2006) Autoinducer 2 controls biofilm formation in Escherichia coli through a novel motility quorum-sensing regulator (MqsR, B3022). J Bacteriol 188: 305-316.
7. Bayles KW (2014) Bacterial programmed cell death: making sense of a paradox. Nat Rev Microbiol 12: 63-69.
8. Bigger JW (1944) Treatment of staphylococcal infections with penicillin. Lancet 244: 497-500.
9. Bjarnsholt T (2013) The role of bacterial biofilms in chronic infections. APMIS 136(Suppl): 1-51.
10. Black DS, Kelly AJ, Mardis MJ., Moyed HS (1991) Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J Bacteriol 173: 5732-5739.
11. Black DS, Irwin B., Moyed HS (1994) Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J Bacteriol 176: 4081-4091.
12. Blower TR, Pei XY, Short FL, Fineran PC, Humphreys DP, Luisi BF., Salmond GPC (2011) A processed noncoding RNA regulates an altruistic bacterial antiviral system. Nat Struct Mol Biol 18: 185-190.
13. Blower TR, Short FL, Rao F, Mizuguchi K, Pei XY, Fineran PC, Luisi BF., Salmond GPC (2012) Identification and classification of bacterial Type III toxin-antitoxin systems encoded in chromosomal and plasmid genomes. Nucleic Acids Res 40: 6158-6173.
14. Brown BL, Lord DM, Grigoriu S, Peti W., Page R (2013) The Escherichia coli toxin MqsR destabilizes the transcriptional repression complex formed between the antitoxin MqsA and the mqsRA operon promoter. J Biol Chem 288: 1286-1294.
15. Castro-Roa D, Garcia-Pino A, De Gieter S, van Nuland NAJ, Loris R & Zenkin N (2013) The Fic protein Doc uses an inverted substrate to phosphorylate and inactivate EF-Tu. Nat Chem Biol 9: 811-817.
16. Cataudella I, Trusina A, Sneppen K, Gerdes K., Mitarai N (2012) Conditional cooperativity in toxin-antitoxin regulation prevents random toxin activation and promotes fast translational recovery. Nucleic Acids Res 40: 6424-6434.
17. Chono H, Matsumoto K, Tsuda H et al. (2011) Acquisition of HIV-1 resistance in T lymphocytes using an ACA-specific E. coli mRNA interferase. Hum Gene Ther 22: 35-43.
18. Conlon BP, Nakayasu ES, Fleck LE, LaFleur MD, Isabella VM, Coleman K, Leonard SN, Smith RD, Adkins JN., Lewis K (2013) Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503: 365-370.
19. Cook GM, Robson JR, Frampton RA, McKenzie J, Przybilski R, Fineran PC., Arcus VL (2013) Ribonucleases in bacterial toxin- antitoxin systems. Biochim Biophys Acta 1829: 523-531.
20. Correia FF, D'Onofrio A, Rejtar T, Li L, Karger BL, Makarova K, Koonin EV., Lewis K (2006) Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J Bacteriol 188: 8360-8367.
21. Dorr T, Vulic M., Lewis K (2010) Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8: e1000317.
22. Engelberg-Kulka H, Hazan R., Amitai S (2005) MazEF: a chromosomal toxin-antitoxin module that triggers programmed cell death in bacteria. J Cell Sci 118: 4327-4332.
23. Engelberg-Kulka H, Amitai S, Kolodkin-Gal I., Hazan R (2006) Bacterial programmed cell death and multicellular behavior in bacteria. PLoS Genet 2: e135.
24. Faridani OR, Nikravesh A, Pandey DP, Gerdes K., Good L (2006) Competitive inhibition of natural antisense Sok-RNA interactions activates Hok-mediated cell killing in Escherichia coli. Nucleic Acids Res 34: 5915-5922.
25. Fasani R., Savageau M (2013) Molecular mechanisms of multiple toxin-antitoxin systems are coordinated to govern the persister phenotype. P Natl Acad Sci USA 110: E2528-E2537.
26. Fineran PC, Blower TR, Foulds IJ, Humphreys DP, Lilley KS., Salmond GPC (2009) The phage abortive infection system, ToxIN, functions as a protein-RNA toxin-antitoxin pair. P Natl Acad Sci USA 106: 894-899.
27. Fozo EM, Hemm MR., Storz G (2008) Small toxic proteins and the antisense RNAs that repress them. Microbiol Mol Biol Rev 72: 579-589.
28. Fozo EM, Makarova KS, Shabalina SA, Yutin N, Koonin EV., Storz G (2010) Abundance of type I toxin-antitoxin systems in bacteria: searches for new candidates and discovery of novel families. Nucleic Acids Res 38: 3743-3759.
29. Gelens L, Hill L, Vandervelde A, Danckaert J., Loris R (2013) A general model for Toxin-Antitoxin module dynamics can explain persister cell formation in E. coli. PLoS Comput Biol 9: e1003190.
30. Georgiades K., Raoult D (2011) Genomes of the most dangerous epidemic bacteria have a virulence repertoire characterized by fewer genes but more toxin-antitoxin modules. PLoS One 6: e17962.
31. Gerdes K., Wagner EGH (2007) RNA antitoxins. Curr Opin Microbiol 10: 117-124.
32. Gerdes K, Larsen JE., Molin S (1985) Stable inheritance of plasmid R1 requires two different loci. J Bacteriol 161: 292-298.
33. Gerdes K, Bech FW, Jorgenson ST, Lobner-Olesen A, Rasmussen PB, Atlung T, Boe L, Karlstrom O, Molin S., von Meyenburg K (1986a) Mechanism of postsegregational killing by the hok gene product of the parB system of plasmid R1 and its homology with the relF gene product of the E. coli relB operon. EMBO J 5: 2023- 2029.
34. Gerdes K, Rasmussen PB., Molin S (1986b) Unique type of plasmid maintenance function: postsegregational killing of plasmid- free cells. P Natl Acad Sci USA 83: 3116-3120.
35. Gerdes K, Poulsen LK, Thisted T, Nielsen AK, Martinussen J., Andreasen PH (1990) The hok killer gene family in gram-negative bacteria. New Biol 2: 946-956.
36. Gerdes K, Nielsen A, Thorsted P., Wagner EG (1992) Mechanism of killer gene activation. Antisense RNA-dependent RNase III cleavage ensures rapid turn-over of the stable hok, srnB and pndA effector messenger RNAs. J Mol Biol 226: 637-649.
37. Germain E, Castro-Roa D, Zenkin N., Gerdes K (2013) Molecular mechanism of bacterial persistence by HipA. Mol Cell 52: 248- 254.
38. Hall-Stoodley L., Stoodley P (2002) Developmental regulation of microbial biofilms. Curr Opin Biotechnol 13: 228-233.
39. Hayes F (2003) Toxins-antitoxins: plasmidmaintenance, programmed cell death, and cell cycle arrest. Science 301: 1496-1499.
40. Hobby GL, Meyer K., Chaffee E (1942) Observations on the mechanism of action of penicillin. Exp Biol Med 50: 281-285.
41. Hurley JM., Woychik N (2009) Bacterial toxin HigB associates with ribosomes and mediates translation-dependent mRNA cleavage at A-rich sites. J Biol Chem 284: 18605-18613.
42. Kasari V, Kurg K, Margus T, Tenson T., Kaldalu N (2010) The Escherichia coli mqsR and ygiT genes encode a new toxin- antitoxin pair. J Bacteriol 192: 2908-2919.
43. Kawano M, Aravind L., Storz G (2007) An antisense RNA controls synthesis of an SOS-induced toxin evolved from an antitoxin. Mol Microbiol 64: 738-754.
44. Keren I, Shah D, Spoering A, Kaldalu N., Lewis K (2004) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186: 8172-8180.
45. Kim Y., Wood TK (2010) Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in Escherichia coli. Biochem Biophys Res Commun 391: 209-213.
46. Kim Y, Wang X, Ma Q, Zhang X-S., Wood TK (2009) Toxin- antitoxin systems in Escherichia coli influence biofilm formation through YjgK (TabA) and fimbriae. J Bacteriol 191: 1258-1267.
47. Kolodkin-Gal I, Hazan R, Gaathon A, Carmeli S., Engelberg-Kulka H (2007) A linear pentapeptide is a quorum-sensing factor required for mazEF-mediated cell death in Escherichia coli. Science 318: 652-655.
48. Kolodkin-Gal I, Verdiger R, Shlosberg-Fedida A., Engelberg-Kulka H (2009) A differential effect of E. coli toxin-antitoxin systems on cell death in liquid media and biofilm formation. PLoS One 4: e6785.
49. Korch SB, Henderson TA., Hill TM (2003) Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol 50: 1199-1213.
50. Kwan BW, Valenta JA, Benedik MJ., Wood TK (2013) Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother 57: 1468-1473.
51. Leplae R, Geeraerts D, Hallez R, Guglielmini J, Dréze P., Van Melderen L (2011) Diversity of bacterial type II toxin-antitoxin systems: a comprehensive search and functional analysis of novel families. Nucleic Acids Res 39: 5513-5525.
52. Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5: 48-56.
53. Lewis K (2010) Persister cells. Annu Rev Microbiol 64: 357-372.
54. Lewis K (2012) Recover the lost art of drug discovery. Nature 485: 439-440.
55. Lewis K (2013) Platforms for antibiotic discovery. Nat Rev Drug Discov 12: 371-387.
56. Ma Z, Geng J, Yi L, Xu B, Jia R, Li Y, Meng Q, Fan H., Hu S (2013) Insight into the specific virulence related genes and toxin- antitoxin virulent pathogenicity islands in swine streptococcosis pathogen Streptococcus equi ssp. zooepidemicus strain ATCC35246. BMC Genomics 14: 377.
57. Maisonneuve E, Shakespeare LJ, Girke M., Gerdes K (2011) Bacterial persistence by RNA endonucleases. P Natl Acad Sci USA 108: 13206-13211.
58. Maisonneuve E, Castro-Camargo M., Gerdes K (2013) (p)ppGpp controls bacterial persistence by stochastic induction of Toxin-Antitoxin activity. Cell 154: 1140-1150.
59. Mandal S, Moudgil M., Mandal SK (2009) Rational drug design. Eur J Pharmacol 625: 90-100.
60. Masuda Y, Miyakawa K, Nishimura Y., Ohtsubo E (1993) chpA and chpB, Escherichia coli chromosomal homologs of the pem locus responsible for stable maintenance of plasmid R100. J Bacteriol 175: 6850-6856.
61. Masuda H, Tan Q, Awano N, Wu K-P., Inouye M (2012) YeeU enhances the bundling of cytoskeletal polymers of MreB and FtsZ, antagonizing the CbtA (YeeV) toxicity in Escherichia coli. Mol Microbiol 84: 979-989.
62. Mitchell HL, Dashper SG, Catmull DV, Paolini RA, Cleal SM, Slakeski N, Tan KH., Reynolds EC (2010) Treponema denticola biofilm-induced expression of a bacteriophage, toxin-antitoxin systems and transposases. Microbiology 156: 774-788.
63. Moritz EM., Hergenrother PJ (2007) Toxin-antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococci. P Natl Acad Sci USA 104: 311-316.
64. Moyed HS., Bertrand KP (1983) HipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 155: 768-775.
65. Moyed HS., Broderick SH (1986) Molecular cloning and expression of hipA, a gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 166: 399-403.
66. Mulcahy LR, Isabella VM., Lewis K (2013) Pseudomonas aeruginosa biofilms in disease. Microb Ecol in press. DOI: 10.1007/ s00248-013-0297-x
67. Mutschler H., Meinhart A (2011) E/Z Systems: their role in resistance, virulence, and their potential for antibiotic development. J Mol Med (Berl) 89: 1183-1194.
68. Mutschler H, Gebhardt M, Shoeman RL., Meinhart A (2011) A novel mechanism of programmed cell death in bacteria by toxin- antitoxin systems corrupts peptidoglycan synthesis. PLoS Biol 9: e1001033.
69. Ogura T., Hiraga S (1983) Mini-F plasmid genes that couple host cell division to plasmid proliferation. P Natl Acad Sci USA 80: 4784-4788.
70. Park SJ, Son WS., Lee B-J (2013) Structural overview of toxin-antitoxin systems in infectious bacteria: a target for developing antimicrobial agents. Biochim Biophys Acta 1834: 1155-1167.
71. Pedersen K., Gerdes K (1999) Multiple hok genes on the chromosome of Escherichia coli. Mol Microbiol 32: 1090-1102.
72. Ramage HR, Connolly LE., Cox JS (2009) Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet 5: e1000767.
73. Ren D, Bedzyk L, Thomas SM, Ye RW., Wood TK (2004) Gene expression in Escherichia coli biofilms. Appl Microbiol Biotechnol 64: 515-524.
74. Ren D, Walker AN., Daines D (2012) Toxin-antitoxin loci vapBC-1 and vapXD contribute to survival and virulence in nontypeable Haemophilus influenzae. BMC Microbiol 12: 263.
75. Rice KC, Mann EE, Endres JL, Weiss EC, Cassat JE, Smeltzer MS., Bayles JW (2007) The cidA murein hydrolase regulator contributes to DNA release and biofilm production in Staphylococcus aureus. P Natl Acad Sci USA 104: 8113-8118.
76. Rotem E, Loinger A, Ronin I, Levin-Reisman I, Gabay C, Shoresh N, Biham O., Balaban NQ (2010) Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. P Natl Acad Sci USA 107: 12541-12546.
77. Rothenbacher FP, Suzuki M, Hurley JM, Montville TJ, Kirn TJ, Ouyang M., Woychik NA (2012) Clostridium difficile MazF toxin exhibits selective, not global, mRNA cleavage. J Bacteriol 194: 3464-3474.
78. Rybtke MT, Jensen PO, Hoiby N, Givskov M, Tolker-Nielsen T., Bjarnsholt T (2011) The Implication of Pseudomonas aeruginosa biofilms in infections. Inflamm Allergy-Drug Targets 10: 141-157.
79. Sayed N, Nonin-Lecomte S, Réty S., Felden B (2012) Functional and structural insights of a Staphylococcus aureus apoptotic-like membrane peptide from a toxin-antitoxin module. J Biol Chem 287: 43454-43463.
80. Sayeed S, Reaves L, Radnedge L., Austin S (2000) The stability region of the large virulence plasmid of Shigella flexneri encodes an efficient postsegregational killing system. J Bacteriol 182: 2416-2421.
81. Sberro H, Leavitt A, Kiro R, Koh E, Peleg Y, Qimron U., Sorek R (2013) Discovery of functional toxin/antitoxin systems in bacteria by shotgun cloning. Mol Cell 50: 136-148.
82. Scherrer R., Moyed HS (1988) Conditional impairment of cell division and altered lethality in hipA mutants of Escherichia coli K-12. J Bacteriol 170: 3321-3326.
83. Schumacher MA, Piro KM, Xu W, Hansen S, Lewis K., Brennan RG (2009) Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science 323: 396-401.
84. Schumacher MA, Min J, Link TM et al. (2012) Role of unusual P loop ejection and autophosphorylation in HipA-mediated persistence and multidrug tolerance. Cell Rep 2: 518-525.
85. Shao Y, Harrison EM, Bi D, Tai C, He X, Ou H-Y, Rajakumar K., Deng Z (2011) TADB: a web-based resource for Type 2 toxin- antitoxin loci in bacteria and archaea. Nucleic Acids Res 39: D606-D611.
86. Shapira A, Gal-Tanamy M, Nahary L, Litvak-Greenfeld D, Zemel R, Tur-Kaspa R., Benhar I (2011) Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain. PLoS One 6: e15916.
87. Shapira A, Shapira S, Gal-Tanamy M, Zemel R, Tur-Kaspa R., Benhar I (2012) Removal of hepatitis C virus-infected cells by a zymogenized bacterial toxin. PLoS One 7: e32320.
88. Short FL, Pei XY, Blower TR, Ong S-L, Fineran PC, Luisi BF., Salmond GPC (2013) Selectivity and self-assembly in the control of a bacterial toxin by an antitoxic noncoding RNA pseudoknot. P Natl Acad Sci USA 110: E241-E249.
89. Soo VWC & Wood TK (2013) AntitoxinMqsA represses curli formation through the master biofilm regulator CsgD. Sci Rep 3: 3186.
90. Stewart PS., Franklin MJ (2008) Physiological heterogeneity in biofilms. Nat Rev Microbiol 6: 199-210.
91. Suzuki M, Zhang J, Liu M, Woychik NA., Inouye M (2005) Single protein production in living cells facilitated by an mRNA interferase. Mol Cell 18: 253-261.
92. Theunissen S, De Smet L, Dansercoer A, Motte B, Coenye T, Van Beeumen JJ, Devreese B, Savvides SN., Vergauwen B (2010) The 285 kDa Bap/RTX hybrid cell surface protein (SO4317) of Shewanella oneidensis MR-1 is a key mediator of biofilm formation. Res Microbiol 161: 144-152.
93. Tripathi A, Dewan PC, Siddique SA., Varadarajan R (2013) MazF induced growth inhibition and persister generation in Escherichia coli. J Biol Chem, in press http://www.jbc.org/cgi/doi/10.1074/jbc. M113.510511
94. Trovatti E, Cotrim CA, Garrido SS, Barros RS., Marchetto R (2008) Peptides based on CcdB protein as novel inhibitors of bacterial topoisomerases. Bioorg Med Chem Lett 18: 6161-6164.
95. Van Melderen L (1996) ATP-dependent degradation of CcdA by Lon protease. Effects of secondary structure and heterologous subunit interactions. J Biol Chem 271: 27730-27738.
96. Van Melderen L., De Bast MS (2009) Bacterial Toxin-Antitoxin systems: more than selfish entities? PLoS Genet 5: e1000437.
97. Von Rosenvinge EC, O'May G, Macfarlane S, Macfarlane GT., Shirtliff ME (2013) Microbial biofilms and gastrointestinal diseases. Pathog Dis 67: 25-38.
98. Wang X., Wood TK (2011) Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl Environ Microbiol 77: 5577-5583.
99. Wang X, Lord DM, Cheng HY et al. (2013) A novel type V TA system where mRNA for toxin GhoT is cleaved by antitoxin GhoS. Nat Chem Biol 8: 855-861.
100. Winther KS., Gerdes K (2011) Enteric virulence associated protein VapC inhibits translation by cleavage of initiator tRNA. P Natl Acad Sci USA 108: 7403-7407.
101. Winther KS, Brodersen DE, Brown AK., Gerdes K (2013) VapC20 of Mycobacterium tuberculosis cleaves the Sarcin-Ricin loop of 23S rRNA. Nat Commun 4: 2796.
102. Wozniak RA., Waldor MK (2009) A toxin-antitoxin system promotes the maintenance of an integrative conjugative element. PLoS Genet 5: e1000439.
103. Yamaguchi Y, Park J-H., Inouye M (2011) Toxin-antitoxin systems in bacteria and archaea. Annu Rev Genet 45: 61-79.
104. Zhang Y, Zhang J, Hoeflich KP, Ikura M, Qing G., Inouye M (2003) MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coli. Mol Cell 12: 913-923.
105. Zhao J, Wang Q, Li M, Heijstra BD, Wang S, Liang Q., Qi Q (2013) Escherichia coli toxin gene hipA affects biofilm formation and DNA release. Microbiology 159: 633-640.
106. Zhu L, Inoue K, Yoshizumi S, Kobayashi H, Zhang Y, Ouyang M, Kato F, Sugai M., Inouye M (2009) Staphylococcus aureus MazF specifically cleaves a pentad sequence, UACAU, which is unusually abundant in the mRNA for pathogenic adhesive factor SraP. J Bacteriol 191: 3248-3255.